CompletedPhase 2NCT02805257
Ahmed Glaucoma Valve Surgery With Mitomycin-C
Studying NON RARE IN EUROPE: Primary adult open-angle glaucoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Ying Han, MD, PhDUniversity of California, San Francisco
- Intervention
- Mitomycin-C(drug)
- Enrollment
- 119 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2016 – 2020
Study locations (4)
- University of California, San Francisco, San Francisco, California, United States
- Zhongshan Ophthalmic Center, Guangzhou, Guangdong, China
- Shri Ganesh Vinayak Eye Hospital, Raipur, Chhattisgarh, India
- Asociación para Evitar la Ceguera en México (APEC), Mexico City, Mexico
Collaborators
Bascom Palmer Eye Institute · University of North Carolina · University of Colorado, Denver · University of Maryland · Zhongshan Ophthalmic Center, Sun Yat-sen University · Asociación para Evitar la Ceguera en México · Hospital Central Militar · Shri Ganesh Vinayak Eye Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02805257 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT07354516Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular HypertensionQlaris Bio, Inc.
- RECRUITINGNCT07303257Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical OptionsHospices Civils de Lyon
- RECRUITINGPHASE1, PHASE2NCT06921317GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle GlaucomaIVIEW Therapeutics Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT07082816Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionAlcon Research
- ACTIVE NOT RECRUITINGPHASE2NCT06030193Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)Qlaris Bio, Inc.
- RECRUITINGNANCT06682962Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle GlaucomaOkuvision GmbH
- RECRUITINGPHASE4NCT06848946Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneGlaukos Corporation
- RECRUITINGNCT06691555Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) ShuntDavinci LTD
See all trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma →